Login / Signup

Mechanism for Stabilizing an Amorphous Drug Using Amino Acids within Co-Amorphous Blends.

Yannick GuinetLaurent PaccouAlain Hédoux
Published in: Pharmaceutics (2023)
Designing co-amorphous formulations is now recognized as a relevant strategy for improving the bioavailability of low-molecular-weight drugs. In order to determine the most suitable low-molecular-weight excipients for stabilizing the drug in the amorphous state, screening methods were developed mostly using amino acids as co-formers. The present study focused on the analysis of the thermal stability of co-amorphous blends prepared by cryo-milling indomethacin with several amino acids in order to understand the stabilization mechanism of the drug in the amorphous state. Combining low- and mid-frequency Raman investigations has provided information on the relation between the physical properties of the blends and those of the H-bond network of the amorphous drug. This study revealed the surprising capabilities of L-arginine to stiffen the H-bond network in amorphous indomethacin and to drastically improve the stability of its amorphous state. As a consequence, this study suggests that amino acids can be considered as stiffeners of the H-bond network of indomethacin, thereby improving the stability of the amorphous state.
Keyphrases
  • room temperature
  • amino acid
  • solid state
  • mental health
  • emergency department
  • nitric oxide
  • high resolution
  • ionic liquid
  • social media